parkinson disease
Conditions
Interventions
The placebo group:The placebo acupuncture and Anti-Parkinson drugsd
Sponsors
the First Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
35 Years to 80 Years
Inclusion criteria
Inclusion criteria: ?Meeting both the diagnosis of primary PD and the diagnostic criteria for insomnia. ?Male or female, aged 35-80 years. ?Patients with Hoehn & Yahr (H-Y) Parkinson's grading scale 1-3 ?The total PDSS score was in the [0,100] range ? Subjects who are informed about the protocol and sign an informed consent form ?Those who can accept non-pharmacological treatment methods such as acupuncture
Exclusion criteria
Exclusion criteria: (i) Those who do not meet any of the above inclusion criteria. (ii) Patients with secondary Parkinson's disease, Parkinson's syndrome or other diseases suspected to be associated with the patient's symptoms, such as Parkinson's superimposed syndrome, senile tremor, etc. (iii) The presence of definite severe other systemic diseases, such as stroke, malignancy, renal failure, diabetes mellitus, atrial fibrillation, and other diseases. (iv) Presence of definite cortical compound sensory loss and limb conceptual motor disuse or progressive aphasia. (v)Patients with severe cognitive dysfunction, blindness, deafness, etc. who are unable to cooperate normally. (vi) Patients who have been taking sleep aids more than 3 times per week for 1 consecutive month. (vii) Patients who have a plan to prepare for pregnancy within 3 months or are pregnant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PDSS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Melatonin;GABA;Epworth Sleepiness Scale;Adverse Events;rapid eye movement sleep behavior disorder scale;Unified Parkinson's Disease Rating Scale;Treatment efficiency; | — |
Countries
china
Contacts
Public ContactLingxing Zhuang
Outcome results
None listed